Updated:
Upcoming Merck KGaA dividendMerck KGaA shows no signs of dividends for 2026.
Merck KGaA, whose ex-dividend was April 27, 2026, credited 2.2 euros on April 29, 2026.
Merck KGaA, listed on the stock market in Germany, the United Kingdom, the United States, Peru, Argentina, among others, using the stock exchange name MRK, began paying dividends in 2002, but it was not until 2008 that it made a firm commitment to this policy.
The amount has remained stable, with fixed and slightly increasing periods, being delivered in four parts, generally in the months of January, April, July and October, reaching an annual yield of approximately 2.83%.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio Merck KGaA Dividends
- Payout Ratio40.37%
- Retained Earnings59.63%
An appropriate payout ratio may vary depending on the industry, the company's growth stage and its financial health.
Dividend calendar of Merck KGaA
There is no Dividend Calendar of Merck KGaA defined for 2026.
For a company to have growing dividends by our standards, the annual dividend amount must have increased steadily for at least the last 5 years.
The company's dividend yield is compared to the industry average to determine its positioning.
Imagine you have a list of dividend yields for different companies in an industry. If you look for the "top 25% percentile", you will find a number. This number tells you that the top 25% of the companies with the highest dividends have a yield higher than that number. On the other hand, the "top 75% percentile" shows you another number, which tells you that 75% of the companies have a higher yield than that number, thus showing a more common and less high yield.
For a company to have stable dividends by our standards, it is vital that it has not had an annual decline of more than 10% over the previous year.
Dividend history of Merck KGaA
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2026 |
04/27/2026 |
2.2 € |
2.2 € |
| 2025 |
04/28/2025 |
2.2 € |
2.2 € |
| 2024 |
04/29/2024 |
2.2 € |
2.2 € |
| 2023 |
05/02/2023 |
2.2 € |
2.2 € |
| 2022 |
04/25/2022 |
1.85 € |
1.85 € |
| 2021 |
04/26/2021 |
1.4 € |
1.4 € |
| 2020 |
05/29/2020 |
1.3 € |
1.3 € |
| 2019 |
04/29/2019 |
1.25 € |
1.25 € |
| 2018 |
04/30/2018 |
1.25 € |
1.25 € |
| 2017 |
05/02/2017 |
1.2 € |
1.2 € |
| 2016 |
05/02/2016 |
1.05 € |
1.05 € |
| 2015 |
04/20/2015 |
1 € |
1.0 € |
| 2014 |
05/12/2014 |
0.95 € |
0.95 € |
| 2013 |
04/29/2013 |
0.85 € |
0.85 € |
| 2012 |
04/23/2012 |
0.75 € |
0.75 € |
| 2011 |
04/11/2011 |
0.625 € |
0.625 € |
| 2010 |
04/12/2010 |
0.5 € |
0.5 € |
| 2009 |
04/06/2009 |
0.75 € |
0.75 € |
| 2007 |
04/30/2007 |
0.525 € |
0.525 € |
| 2006 |
07/03/2006 |
0.418471 € |
0.4185 € |
| 2005 |
04/01/2005 |
0.492319 € |
0.4923 € |
| 2004 |
03/29/2004 |
0.393855 € |
0.3939 € |
| 2003 |
03/31/2003 |
0.492319 € |
0.4923 € |
| 2002 |
03/25/2002 |
0.467703 € |
0.4677 € |
| 2001 |
04/06/2001 |
0.443087 € |
0.4431 € |
| 2000 |
05/12/2000 |
0.418471 € |
0.4185 € |
Information about Merck KGaA
Merck KGaA, is an important multinational company specialized in the manufacture of pharmaceuticals, biotechnology and chemicals, has its headquarters in Germany, being one of the oldest in the world and is known as Merk KGaA, which indicates that it is a limited stock company.
Its origins are associated with the acquisition of the Angel Pharmacy (Engel-Apotheke) in 1668 by Friedrich Jacob Merck, producing in 1827 chemical products, alkaloids and some plant extracts, which generated much success, allowing it to export its products to the United States some sixty years later, thus opening its first international subsidiary in New York, forming Merk & Co. in 1891.
Due to the consequences of World War I, it becomes an American company with rights within North America, operating in other countries under the name of Merck KGaA, or MSD Sharp & Dohme.
The company made a series of acquisitions highlighting the acquisition of Serono in 2006, thereby strengthening its market in Switzerland, obtaining strengths in the biotechnology industry, in 2010, meanwhile, they bought Millipore Corporation joining the chemical division of Merck and in 2014 that of the Sigma-Aldrich group, an important manufacturer of chemical components located mainly in the United States.
Its business areas are classified as follows:
- Health Division, specializing in Neurology and Immunology, Oncology, Fertility, Endocrinology and General Medicine.
- Life Sciences Division, focused on Clinical and Diagnostics, Emerging Biotechnologies, Environmental Analysis, Industrial Solutions, Pharmaceutical and Biopharmaceutical Production, Food and Beverage Solutions and Pharmaceutical Quality Control.
- High-performance materials, creating Automotive and Architectural Solutions, Displays, Effect Pigments, Cosmetics, Functional Technologies, Optoelectronics and Semiconductors.
Frequently asked questions about Merck KGaA dividends
Merck KGaA pays dividends on a Annual basis.
Merck KGaA is listed on the Bolsa de Fráncfort and is part of the DAX 40.
Merck KGaA has the Ticker or stock code MRK.
The CEO of Merck KGaA in 2026 is Ms. Belen Garijo Lopez M.D..
The ISIN of Merck KGaA is DE0006599905.
Merck KGaA does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.
Check the latest comments and participate in the live chat on Merck KGaA stocks (MRK).
No comments yet. Be the first to join in.